Clinical Medicine News
-
Showcase
Synaptive Medical Receives FDA 510(k) Clearance for Near-Infrared Fluorescence Visualization, Expanding Application of Existing Robotic Exoscope
Near-Infrared fluorescence now available on Modus X robotic exoscope, complementing system’s existing advanced fluorescence capabilities New Infrared fluorescence enables the use of Modus X for visualization of vessels in conjunction with indocyanine green New patented 4K ICG Image Fusion for real-time contrast of microsurgical vessels against background anatomy Synaptive Medical ...
-
Showcase
FDA Emerging Technology Program
Broomfield Colorado 6/16/2022. Aktiv Pharma Group (Aktiv) announced today the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for sterile injectables named ARCH, into the US Food and Drug Administration (FDA) Emerging Technology Program (ETP). The ETP is a collaborative effort which supports the FDA’s mission to facilitate modernization in ...
-
Showcase
Neeuro (Singapore) and epihunter (Belgium) partner to create new and innovative digital solutions for people with brain disorders
On March 15th 2015, Tim Buckinx’ son said: “Papa, you work in digital, can’t you create a light that turns on when my brain switches off?” At ten years old, he was simply fed up with the daily impact of his refractory epilepsy. That pain became a vision, and that vision became the Belgian digital therapeutics company epihunter, aimed at enabling people with a brain ...
By Epihunter NV
-
Showcase
Corify Care raises €2.35M to translate its cardiac mapping technology to the market. .
- Corify Care is developing ACORYS®, a non-invasive cardiac mapping medical device to transform the cardiac arrhythmia treatment process. - The investment round is led by Clave Capital, counting with investment from CDTI through its Innvierte program and the support from Genesis Biomed. Corify Care, the developer of an innovative and completely non-invasive cardiac mapping system, ...
-
Showcase
Empatica partnering with U.S. Army MRDC to deploy COVID-19 early detection wearable
BOSTON, Nov. 6, 2020 /PRNewswire/ -- Empatica has been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to deploy a wearable and algorithm that enable the early and pre-symptomatic detection of COVID-19. The project's focus is on protecting the health of the general population by preventing outbreaks via early detection and alerting. Empatica's Aura algorithm gives a ...
-
Showcase
Empatica and BARDA Join Forces to Validate Wearable System That Detects COVID-19 Before Symptoms Appear
BOSTON, June 19, 2020 /PRNewswire/ -- Digital healthcare company Empatica announces a pioneering new partnership with the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), to validate an early warning system for COVID-19 and other respiratory ...
-
CD Formulation Incorporates Phase Separation Method for Microsphere Production
In the ever-evolving field of pharmaceuticals, continuous innovation is key to developing new drug delivery systems that can improve patient outcomes and increase therapeutic efficacy. One such innovation is the use of phase separation technology for the production of microspheres, a method that has recently been incorporated into CD Formulation’s controlled-release drug delivery systems. ...
-
CD Formulation Introduces Microneedle Patch Innovations for Enhanced Drug Delivery Efficiency
CD Formulation, a leading innovator in drug delivery technologies, has recently introduced a series of groundbreaking microneedle patch innovations that promise to revolutionize the way drugs are administered. Microneedle patches are a novel drug delivery system that utilizes tiny needles to painlessly penetrate the skin's outer layer and deliver medication directly into the bloodstream. This ...
-
CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies
CD Formulation, a company in the field of biopharmaceutical studies, is revolutionizing the way impurity determination is conducted in the industry. With the use of advanced technology and cutting-edge methodologies, CD Formulation offers accurate and reliable testing for a wide range of impurities, ensuring the safety and effectiveness of pharmaceutical products. The expertise in organic ...
-
CD Formulation Shows the Ability of Coated Microneedle Preparation Technology for Novel Drug Delivery
Advancements in drug delivery technology have paved the way for more efficient and targeted treatment options. Among these innovations is the development of coated microneedle preparation technology, which has shown promising results in delivering novel drugs to patients. CD formulation involves coated microneedles with specific drug compounds, allowing for controlled and sustained drug delivery. ...
-
Novel Drug Delivery System Unveiled: CD Formulation Launches Oral Thin Films Technology
In a groundbreaking development in the field of pharmaceuticals, CD Formulation, a prominent drug formulation company, has announced the launch of Oral Thin Film Technology. This cutting-edge drug delivery system is poised to revolutionize medication administration, offering patients a more convenient and effective treatment method. Oral Thin Film Technology is a user-friendly drug delivery ...
-
Alfa Chemistry Recently Launched a Sub-website for Functional Polymers
The US-based chemical supplier Alfa Chemistry announced the launch of a new sub-website for the supply of functional polymers, including Adsorptive Polymers, Biomedical Polymers, Electrofunctional Polymers, Functional PEGs, Photoactive Polymers, Silicone Polymers and more. With unstopping efforts, the company continues to offer chemicals for specialized applications, such as catalysts, fatty ...
-
Alfa Chemistry Provides Customized Synthesis Services for Biotinylation Reagents
Alfa Chemistry, a globally recognized chemical supplier, has recently announced its expanded range of services for customized synthesis of biotinylation reagents. Biotinylation, a widely used biological technique, involves the covalent attachment of biotin to biomolecules such as proteins, peptides, and nucleic acids. This technique plays a crucial role in various research fields, including ...
-
Caresyntax Announces Highlights of 2023
Caresyntax, the leading vendor of enterprise-scale data-driven surgical intelligence solutions to make surgery safer and smarter, today announced its highlights and achievements of 2023, as the company has continued its strong growth journey. Dennis Kogan, co-founder, and CEO: “Caresyntax celebrated its 10-year anniversary in 2023 and accelerated our journey of innovation and expansion ...
By Caresyntax
-
CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced an expanded portfolio of Polydimethylsiloxane (PDMS) products, empowering researchers with versatile and biocompatible tools for groundbreaking discoveries. Polydimethylsiloxane is an elastomeric polymer with interesting properties for biomedical applications, including ...
-
CD Formulation Unveils Prominent Pharmaceutical Ingredients and Excipients for Enhanced Medicine Efficacy
In the quest to develop safe and effective medicines, pharmaceutical companies rely on the precise combination of active pharmaceutical ingredients (APIs) and excipients. These crucial components play a pivotal role in the formulation of pharmaceutical drugs, ensuring optimal drug delivery and patient outcomes. Recently, CD Formulation released a comprehensive guide titled "Active Pharmaceutical ...
-
CD Formulation Excels in Developing and Optimizing Micro-Reservoir Controlled-Release Drug Delivery Systems
CD Formulation has been dedicated to pharmaceutical advancements, showcasing immense expertise in the development and optimization of micro-reservoir controlled-release drug delivery systems. These innovative systems have revolutionized the way medications are administered, enhancing patient comfort and ensuring optimal therapeutic efficacy. Transdermal drug delivery systems are very popular ...
-
Caresyntax Announces Launch of Novel Real World Evidence (RWE) Program and Software Portfolio of Digital Catalysts for Commercial Acceleration of Medtech Partners
Caresyntax, the leading vendor-neutral surgical data and intelligence platform converging AI-powered software, devices, and clinical services, today announced the launch of Caresyntax Clinical Data as a Service (CDaaS) for Medtech industry partners. The launch of Caresyntax CDaaS follows the recently announced addition of CQInsights (CQI) and appointment of Dr. Bruce Ramshaw as Chief Medical ...
By Caresyntax
-
Vantage Welcomes Saint Catherine’s Hospice!
We are delighted to welcome Saint Catherine’s Hospice Scarborough to the growing community of amazing hospice charities we work with across the UK. We are proud to provide Saint Catherine’s with our affordable and adaptable software solutions that support the outstanding care they provide to people with life-limiting ...
-
How ReFlow Helped Get Zachary’s Hydrocephalus Under Control and Travel Across the Globe
Even before Zachary was born nearly 11 years ago, his parents Sherry and Jason knew that he was going to be a special boy – and a wonderful sibling to a twin sister! Zachary was born with spina bifida and hydrocephalus, both of which were diagnosed while in utero. As with many children in the hydrocephalus community, most parents have never heard of the condition, nor understand how it ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you